Wageningen, Netherlands
January 11, 2016

KeyGene announces today that it has licensed its proprietary Sequence-Based Genotyping (SBG) methods to Bayer’s Crop Science division. Under the agreement Bayer’s Crop Science division obtains a non-exclusive licence for the in-house use of the SBG technology for crop improvement. SBG methods are highly cost-effective to identify and score thousands of DNA markers. The use of SBG accelerates genetic improvement of crops with novel traits, thereby providing solutions to feed the world in a sustainable way. Financial terms of the agreement were not disclosed.

"KeyGene is delighted with licensing its global SBG patent portfolio to Bayer’s Crop Science division, an innovation-driven enterprise with competencies in the field of agriculture", said Michiel van Eijk, CSO of KeyGene. "This licence agreement with Bayer’s Crop Science division supports our shared commitment to crop improvement and meeting the challenges of sustainable food supply".

About KeyGene
The crop innovation company
KeyGene is a privately owned Ag Biotech company with its primary focus on crop innovation. KeyGene’s approach is to enable molecular genetics for the future of global agriculture. KeyGene supports its strategic partners with cutting edge breeding technologies, bioinformatics and plant-based trait platforms, with more than 135 employees worldwide. KeyGene has sites in Wageningen, the Netherlands and in Rockville, USA.

Website: http://www.keygene.com

Published: January 11, 2016